Filing Flows › Mimedx Group (MDXG) › Q1 2025
Mimedx Group (MDXG) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 30, 2025
Mimedx Group (MDXG) reported revenue of $88.2M for the first quarter 2025 (Q1 2025), +4% from a year earlier and -5% from the quarter before. Operating margin was 9.4%, net earnings $7.0M (8.0% of revenue).
Mimedx Group, Q1 2025: revenue $88.2M (+4% year over year), operating margin 9.4%, net earnings $7.0M, operating cash flow $5.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $88.2M | -5% | +4% |
| Gross profit | $71.6M | -6% | -0.1% |
| Operating profit | $8.3M | -25% | -37% |
| Net earnings | $7.0M | -6% | -24% |
| Operating cash flow | $5.3M | -72% | -11% |
| Free cash flow | $4.9M | — | +2% |
What changed
Revenue was $88.2M in Q1 2025, up 4% year over year and down 5% from the previous quarter. Wound was the largest line at 64% of revenue. Surgical added $4.5M year over year (up 16%), 128% of the total change. Wound declined 2%.
Gross margin was 81.2%, down 3.4 points from a year earlier. Operating profit was $8.3M, a 9.4% margin (down 6.2 points year over year). Operating profit fell $4.9M even though revenue rose $3.5M versus a year earlier, so costs grew faster than sales. Operating expenses grew 8% against revenue growth of 4%. The fastest-growing cost line was General & admin (+23%). Net earnings were $7.0M, down 24% year over year. The effective tax rate was 18.5%.
Operating cash flow was $5.3M (down 11% year over year), 75% of net earnings. Non-cash charges added back $657K of depreciation and amortization and $4.3M of share-based compensation. Working capital and other items used $6.6M. Capital expenditures of $377K left free cash flow of $4.9M.
Questions
What was Mimedx Group's revenue in the first quarter 2025?
Mimedx Group (MDXG) reported revenue of $88.2M for the first quarter 2025 (Q1 2025), +4% from a year earlier and -5% from the quarter before.
Was Mimedx Group profitable in the first quarter 2025?
Operating profit was $8.3M (9.4% of revenue) and net earnings $7.0M.
Source: Mimedx Group 10-Q on SEC EDGAR.